GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Vimian Group AB (FRA:0V0) » Definitions » EV-to-FCF

Vimian Group AB (FRA:0V0) EV-to-FCF : 57.84 (As of Dec. 11, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Vimian Group AB EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Vimian Group AB's Enterprise Value is €2,066.6 Mil. Vimian Group AB's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was €35.7 Mil. Therefore, Vimian Group AB's EV-to-FCF for today is 57.84.

The historical rank and industry rank for Vimian Group AB's EV-to-FCF or its related term are showing as below:

FRA:0V0' s EV-to-FCF Range Over the Past 10 Years
Min: -242.51   Med: 78.28   Max: 738.73
Current: 60.79

During the past 7 years, the highest EV-to-FCF of Vimian Group AB was 738.73. The lowest was -242.51. And the median was 78.28.

FRA:0V0's EV-to-FCF is ranked worse than
77.55% of 98 companies
in the Medical Diagnostics & Research industry
Industry Median: 27.045 vs FRA:0V0: 60.79

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-11), Vimian Group AB's stock price is €3.54. Vimian Group AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was €0.005. Therefore, Vimian Group AB's PE Ratio (TTM) for today is 708.00.


Vimian Group AB EV-to-FCF Historical Data

The historical data trend for Vimian Group AB's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vimian Group AB EV-to-FCF Chart

Vimian Group AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial - - 693.11 84.68 -34.18

Vimian Group AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.17 -34.18 -45.46 54.74 66.47

Competitive Comparison of Vimian Group AB's EV-to-FCF

For the Diagnostics & Research subindustry, Vimian Group AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vimian Group AB's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Vimian Group AB's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Vimian Group AB's EV-to-FCF falls into.



Vimian Group AB EV-to-FCF Calculation

Vimian Group AB's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2066.572/35.732
=57.84

Vimian Group AB's current Enterprise Value is €2,066.6 Mil.
Vimian Group AB's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €35.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vimian Group AB  (FRA:0V0) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Vimian Group AB's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=3.54/0.005
=708.00

Vimian Group AB's share price for today is €3.54.
Vimian Group AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.005.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Vimian Group AB EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Vimian Group AB's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Vimian Group AB Business Description

Traded in Other Exchanges
Address
Riddargatan 19, Stockholm, SWE, SE-11457
Vimian Group AB specializes in the areas of animal health such as specialty pharma, diagnostics, medtech, and veterinary services. It offers proprietary diagnostics, prescription and non-prescription treatments for preventive care, and treatment of chronic conditions for companion animals, with a strong position within allergy, dermatology, otology, and specialized nutrition. Its geographical segments include Europe, North America, and the Rest of the world.

Vimian Group AB Headlines

No Headlines